Global Chicken Newcastle Disease Vaccine 麻豆原创 Research Report 2025

Publication ID:

PB504260387

Publication Date:

May 2, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global market for Chicken Newcastle Disease Vaccine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Chicken Newcastle Disease Vaccine is a monovalent live virus vaccine for the immunization of chickens against Newcastle disease.
North American market for Chicken Newcastle Disease Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Chicken Newcastle Disease Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Chicken Newcastle Disease Vaccine include Boehringer-Ingelheim, Merial, CEVA, QYH Biotech, Merck Animal Health, Zoetis, Elanco (Lohmann), FATRO, Vaksindo, Ringpu, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Chicken Newcastle Disease Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chicken Newcastle Disease Vaccine.
The Chicken Newcastle Disease Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Chicken Newcastle Disease Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chicken Newcastle Disease Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Boehringer-Ingelheim
Merial
CEVA
QYH Biotech
Merck Animal Health
Zoetis
Elanco (Lohmann)
FATRO
Vaksindo
Ringpu
Yebio
Harvac
Chengdu SG-Biotech
Harbin Pharmaceutical Group
Segment by Type
Live Vaccine
Inactivated Vaccine
Segment by Application
Chicken
Adult Chicken
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Chicken Newcastle Disease Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Chicken Newcastle Disease Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Chicken Newcastle Disease Vaccine 麻豆原创 Overview
1.1 Product Definition
1.2 Chicken Newcastle Disease Vaccine by Type
1.2.1 Global Chicken Newcastle Disease Vaccine 麻豆原创 Value Comparison by Type (2024 VS 2031)
1.2.2 Live Vaccine
1.2.3 Inactivated Vaccine
1.3 Chicken Newcastle Disease Vaccine by Application
1.3.1 Global Chicken Newcastle Disease Vaccine 麻豆原创 Value by Application (2024 VS 2031)
1.3.2 Chicken
1.3.3 Adult Chicken
1.4 Global Chicken Newcastle Disease Vaccine 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Chicken Newcastle Disease Vaccine Revenue 2020-2031
1.4.2 Global Chicken Newcastle Disease Vaccine Sales 2020-2031
1.4.3 Global Chicken Newcastle Disease Vaccine 麻豆原创 Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Chicken Newcastle Disease Vaccine 麻豆原创 Competition by Manufacturers
2.1 Global Chicken Newcastle Disease Vaccine Sales 麻豆原创 Share by Manufacturers (2020-2025)
2.2 Global Chicken Newcastle Disease Vaccine Revenue 麻豆原创 Share by Manufacturers (2020-2025)
2.3 Global Chicken Newcastle Disease Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Chicken Newcastle Disease Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Chicken Newcastle Disease Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Chicken Newcastle Disease Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Chicken Newcastle Disease Vaccine, Date of Enter into This Industry
2.8 Global Chicken Newcastle Disease Vaccine 麻豆原创 Competitive Situation and Trends
2.8.1 Global Chicken Newcastle Disease Vaccine 麻豆原创 Concentration Rate
2.8.2 The Global 5 and 10 Largest Chicken Newcastle Disease Vaccine Players 麻豆原创 Share by Revenue
2.8.3 Global Chicken Newcastle Disease Vaccine 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Chicken Newcastle Disease Vaccine 麻豆原创 Scenario by Region
3.1 Global Chicken Newcastle Disease Vaccine 麻豆原创 Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Chicken Newcastle Disease Vaccine Sales by Region: 2020-2031
3.2.1 Global Chicken Newcastle Disease Vaccine Sales by Region: 2020-2025
3.2.2 Global Chicken Newcastle Disease Vaccine Sales by Region: 2026-2031
3.3 Global Chicken Newcastle Disease Vaccine Revenue by Region: 2020-2031
3.3.1 Global Chicken Newcastle Disease Vaccine Revenue by Region: 2020-2025
3.3.2 Global Chicken Newcastle Disease Vaccine Revenue by Region: 2026-2031
3.4 North America Chicken Newcastle Disease Vaccine 麻豆原创 Facts & Figures by Country
3.4.1 North America Chicken Newcastle Disease Vaccine 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Chicken Newcastle Disease Vaccine Sales by Country (2020-2031)
3.4.3 North America Chicken Newcastle Disease Vaccine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Chicken Newcastle Disease Vaccine 麻豆原创 Facts & Figures by Country
3.5.1 Europe Chicken Newcastle Disease Vaccine 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Chicken Newcastle Disease Vaccine Sales by Country (2020-2031)
3.5.3 Europe Chicken Newcastle Disease Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Chicken Newcastle Disease Vaccine 麻豆原创 Facts & Figures by Region
3.6.1 Asia Pacific Chicken Newcastle Disease Vaccine 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Chicken Newcastle Disease Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific Chicken Newcastle Disease Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Chicken Newcastle Disease Vaccine 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Chicken Newcastle Disease Vaccine 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Chicken Newcastle Disease Vaccine Sales by Country (2020-2031)
3.7.3 Latin America Chicken Newcastle Disease Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Chicken Newcastle Disease Vaccine 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Chicken Newcastle Disease Vaccine 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Chicken Newcastle Disease Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Chicken Newcastle Disease Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Chicken Newcastle Disease Vaccine Sales by Type (2020-2031)
4.1.1 Global Chicken Newcastle Disease Vaccine Sales by Type (2020-2025)
4.1.2 Global Chicken Newcastle Disease Vaccine Sales by Type (2026-2031)
4.1.3 Global Chicken Newcastle Disease Vaccine Sales 麻豆原创 Share by Type (2020-2031)
4.2 Global Chicken Newcastle Disease Vaccine Revenue by Type (2020-2031)
4.2.1 Global Chicken Newcastle Disease Vaccine Revenue by Type (2020-2025)
4.2.2 Global Chicken Newcastle Disease Vaccine Revenue by Type (2026-2031)
4.2.3 Global Chicken Newcastle Disease Vaccine Revenue 麻豆原创 Share by Type (2020-2031)
4.3 Global Chicken Newcastle Disease Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Chicken Newcastle Disease Vaccine Sales by Application (2020-2031)
5.1.1 Global Chicken Newcastle Disease Vaccine Sales by Application (2020-2025)
5.1.2 Global Chicken Newcastle Disease Vaccine Sales by Application (2026-2031)
5.1.3 Global Chicken Newcastle Disease Vaccine Sales 麻豆原创 Share by Application (2020-2031)
5.2 Global Chicken Newcastle Disease Vaccine Revenue by Application (2020-2031)
5.2.1 Global Chicken Newcastle Disease Vaccine Revenue by Application (2020-2025)
5.2.2 Global Chicken Newcastle Disease Vaccine Revenue by Application (2026-2031)
5.2.3 Global Chicken Newcastle Disease Vaccine Revenue 麻豆原创 Share by Application (2020-2031)
5.3 Global Chicken Newcastle Disease Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Boehringer-Ingelheim
6.1.1 Boehringer-Ingelheim Company Information
6.1.2 Boehringer-Ingelheim Description and Business Overview
6.1.3 Boehringer-Ingelheim Chicken Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Boehringer-Ingelheim Chicken Newcastle Disease Vaccine Product Portfolio
6.1.5 Boehringer-Ingelheim Recent Developments/Updates
6.2 Merial
6.2.1 Merial Company Information
6.2.2 Merial Description and Business Overview
6.2.3 Merial Chicken Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Merial Chicken Newcastle Disease Vaccine Product Portfolio
6.2.5 Merial Recent Developments/Updates
6.3 CEVA
6.3.1 CEVA Company Information
6.3.2 CEVA Description and Business Overview
6.3.3 CEVA Chicken Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 CEVA Chicken Newcastle Disease Vaccine Product Portfolio
6.3.5 CEVA Recent Developments/Updates
6.4 QYH Biotech
6.4.1 QYH Biotech Company Information
6.4.2 QYH Biotech Description and Business Overview
6.4.3 QYH Biotech Chicken Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 QYH Biotech Chicken Newcastle Disease Vaccine Product Portfolio
6.4.5 QYH Biotech Recent Developments/Updates
6.5 Merck Animal Health
6.5.1 Merck Animal Health Company Information
6.5.2 Merck Animal Health Description and Business Overview
6.5.3 Merck Animal Health Chicken Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Merck Animal Health Chicken Newcastle Disease Vaccine Product Portfolio
6.5.5 Merck Animal Health Recent Developments/Updates
6.6 Zoetis
6.6.1 Zoetis Company Information
6.6.2 Zoetis Description and Business Overview
6.6.3 Zoetis Chicken Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Zoetis Chicken Newcastle Disease Vaccine Product Portfolio
6.6.5 Zoetis Recent Developments/Updates
6.7 Elanco (Lohmann)
6.7.1 Elanco (Lohmann) Company Information
6.7.2 Elanco (Lohmann) Description and Business Overview
6.7.3 Elanco (Lohmann) Chicken Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Elanco (Lohmann) Chicken Newcastle Disease Vaccine Product Portfolio
6.7.5 Elanco (Lohmann) Recent Developments/Updates
6.8 FATRO
6.8.1 FATRO Company Information
6.8.2 FATRO Description and Business Overview
6.8.3 FATRO Chicken Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 FATRO Chicken Newcastle Disease Vaccine Product Portfolio
6.8.5 FATRO Recent Developments/Updates
6.9 Vaksindo
6.9.1 Vaksindo Company Information
6.9.2 Vaksindo Description and Business Overview
6.9.3 Vaksindo Chicken Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Vaksindo Chicken Newcastle Disease Vaccine Product Portfolio
6.9.5 Vaksindo Recent Developments/Updates
6.10 Ringpu
6.10.1 Ringpu Company Information
6.10.2 Ringpu Description and Business Overview
6.10.3 Ringpu Chicken Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Ringpu Chicken Newcastle Disease Vaccine Product Portfolio
6.10.5 Ringpu Recent Developments/Updates
6.11 Yebio
6.11.1 Yebio Company Information
6.11.2 Yebio Description and Business Overview
6.11.3 Yebio Chicken Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Yebio Chicken Newcastle Disease Vaccine Product Portfolio
6.11.5 Yebio Recent Developments/Updates
6.12 Harvac
6.12.1 Harvac Company Information
6.12.2 Harvac Description and Business Overview
6.12.3 Harvac Chicken Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Harvac Chicken Newcastle Disease Vaccine Product Portfolio
6.12.5 Harvac Recent Developments/Updates
6.13 Chengdu SG-Biotech
6.13.1 Chengdu SG-Biotech Company Information
6.13.2 Chengdu SG-Biotech Description and Business Overview
6.13.3 Chengdu SG-Biotech Chicken Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Chengdu SG-Biotech Chicken Newcastle Disease Vaccine Product Portfolio
6.13.5 Chengdu SG-Biotech Recent Developments/Updates
6.14 Harbin Pharmaceutical Group
6.14.1 Harbin Pharmaceutical Group Company Information
6.14.2 Harbin Pharmaceutical Group Description and Business Overview
6.14.3 Harbin Pharmaceutical Group Chicken Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Harbin Pharmaceutical Group Chicken Newcastle Disease Vaccine Product Portfolio
6.14.5 Harbin Pharmaceutical Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Chicken Newcastle Disease Vaccine Industry Chain Analysis
7.2 Chicken Newcastle Disease Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Chicken Newcastle Disease Vaccine Production Mode & Process Analysis
7.4 Chicken Newcastle Disease Vaccine Sales and 麻豆原创ing
7.4.1 Chicken Newcastle Disease Vaccine Sales Channels
7.4.2 Chicken Newcastle Disease Vaccine Distributors
7.5 Chicken Newcastle Disease Vaccine Customer Analysis
8 Chicken Newcastle Disease Vaccine 麻豆原创 Dynamics
8.1 Chicken Newcastle Disease Vaccine Industry Trends
8.2 Chicken Newcastle Disease Vaccine 麻豆原创 Drivers
8.3 Chicken Newcastle Disease Vaccine 麻豆原创 Challenges
8.4 Chicken Newcastle Disease Vaccine 麻豆原创 Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Boehringer-Ingelheim
Merial
CEVA
QYH Biotech
Merck Animal Health
Zoetis
Elanco (Lohmann)
FATRO
Vaksindo
Ringpu
Yebio
Harvac
Chengdu SG-Biotech
Harbin Pharmaceutical Group

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.